Day 2 - Afternoon

Group 5A: HER2+ Breast & Pan-Cancers; Clinical Trials; Immunotherapy; Novel Targets & Therapies Sold Out

Group 5B: HER2-low & HER2-negative Breast Cancer; Targeted Therapies Last Few Tickets

Group 5C: HR+ Breast Cancer; Clinical Trials; Novel Targets & Therapies; Treatment Resistance Sold Out

Group 5D: Triple Negative & Pan-Cancers; Immunotherapy; Real-World Data/Outcomes; Treatment Resistance Last Few Tickets

Group 5E: Breast Cancer; Biomarkers; Tumor Biology

Group 5F: HR+ Breast Cancer; Clinical Trials; Hormone Therapies; Targeted Therapies; Treatment Resistance Sold Out